Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the successful completion of process tech transfer ...
Nuvation Bio, a New York-based oncology company, said it completed a technology transfer and product introduction to Waltham, Mass.-based Thermo Fisher Scientific for Ibtrozi, a treatment for ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has been recognized by the R&D 100 Awards, honoring the top 100 revolutionary products in science ...
Thermo Scientific™ KingFisher™ PlasmidPro prepares high purity plasmid DNA in approximately 75 minutes, half the traditional process time and without the need for centrifugation WALTHAM, ...
April 23 (Reuters) - Thermo Fisher Scientific on Thursday reported first-quarter profit and revenue above Wall Street estimates, as growth in its laboratory products and biopharma services business ...
Wondering if Thermo Fisher Scientific at around US$472.95 is offering good value right now, or if the stock has already run ...
Biotechnology giant Thermo Fisher Scientific announced the opening of a US Bioprocess Design Center (BDC) on its campus in ...
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.
For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of this release. Supplemental Information ...
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through ...